BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 29213456)

  • 1. Delayed recall memory impairment in patients with Parkinson's disease.
    Schelp AO; Mendes-Chiloff CL; Paduan VC; Corrente JE; de Lima FD; Marchette JCN; Luvizuto GJ; Bazan R
    Dement Neuropsychol; 2016; 10(3):204-209. PubMed ID: 29213456
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amnestic dementia impairment in Parkinson's disease: The role of body composition, ageing and insulin resistance.
    Schelp AO; Mendes-Chiloff CL; Paduan VC; Corrente JE; Vieira A; Marchette JCN; de Souza JT; Luvizuto GJ; Nogueira CR; Bazan R
    Clin Nutr ESPEN; 2017 Aug; 20():47-51. PubMed ID: 29072169
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CERAD test performance and cognitive impairment in Parkinson's disease.
    Karrasch M; Laatu S; Martikainen K; Marttila R
    Acta Neurol Scand; 2013 Dec; 128(6):409-13. PubMed ID: 23668316
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuropsychological impairment in Parkinson's disease with and without depression.
    Tröster AI; Stalp LD; Paolo AM; Fields JA; Koller WC
    Arch Neurol; 1995 Dec; 52(12):1164-9. PubMed ID: 7492290
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cut-off score of the Mattis Dementia Rating Scale for screening dementia in Parkinson's disease.
    Llebaria G; Pagonabarraga J; Kulisevsky J; García-Sánchez C; Pascual-Sedano B; Gironell A; Martínez-Corral M
    Mov Disord; 2008 Aug; 23(11):1546-50. PubMed ID: 18546326
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cognitive impairment in early-stage non-demented Parkinson's disease patients.
    Pfeiffer HC; Løkkegaard A; Zoetmulder M; Friberg L; Werdelin L
    Acta Neurol Scand; 2014 May; 129(5):307-18. PubMed ID: 24117192
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mattis Dementia Rating Scale 2: screening for MCI and dementia.
    Matteau E; Dupré N; Langlois M; Jean L; Thivierge S; Provencher P; Simard M
    Am J Alzheimers Dis Other Demen; 2011 Aug; 26(5):389-98. PubMed ID: 21697143
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Accuracy of Two Cognitive Screening Tools to Detect Mild Cognitive Impairment in Parkinson's Disease.
    Koevoets EW; Schmand B; Geurtsen GJ
    Mov Disord Clin Pract; 2018; 5(3):259-264. PubMed ID: 30363408
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Parkinson's disease-cognitive rating scale: a new cognitive scale specific for Parkinson's disease.
    Pagonabarraga J; Kulisevsky J; Llebaria G; García-Sánchez C; Pascual-Sedano B; Gironell A
    Mov Disord; 2008 May; 23(7):998-1005. PubMed ID: 18381647
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cholinesterase inhibitors for dementia with Lewy bodies, Parkinson's disease dementia and cognitive impairment in Parkinson's disease.
    Rolinski M; Fox C; Maidment I; McShane R
    Cochrane Database Syst Rev; 2012 Mar; 2012(3):CD006504. PubMed ID: 22419314
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical Characterization of Parkinson's Disease Patients With Cognitive Impairment.
    Simon-Gozalbo A; Rodriguez-Blazquez C; Forjaz MJ; Martinez-Martin P
    Front Neurol; 2020; 11():731. PubMed ID: 32849203
    [No Abstract]   [Full Text] [Related]  

  • 12. Memory and executive function impairment predict dementia in Parkinson's disease.
    Levy G; Jacobs DM; Tang MX; Côté LJ; Louis ED; Alfaro B; Mejia H; Stern Y; Marder K
    Mov Disord; 2002 Nov; 17(6):1221-6. PubMed ID: 12465060
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mild cognitive impairment in Parkinson's disease and its progression onto dementia: a 16-year outcome evaluation of the Denbighshire cohort.
    Hobson P; Meara J
    Int J Geriatr Psychiatry; 2015 Oct; 30(10):1048-55. PubMed ID: 25676160
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cognitive profiles and optimal cut-offs for routine cognitive tests in elderly individuals with Parkinson's disease, Parkinson's disease dementia, Alzheimer's disease, and normal cognition.
    Phannarus H; Muangpaisan W; Siritipakorn P; Chotinaiwattarakul W
    Psychogeriatrics; 2020 Jan; 20(1):20-27. PubMed ID: 30912230
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Which Neuropsychological Tests? Predicting Cognitive Decline and Dementia in Parkinson's Disease in the ICICLE-PD Cohort.
    Lawson RA; Williams-Gray CH; Camacho M; Duncan GW; Khoo TK; Breen DP; Barker RA; Rochester L; Burn DJ; Yarnall AJ;
    J Parkinsons Dis; 2021; 11(3):1297-1308. PubMed ID: 34024781
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sensitivity and specificity of Addenbrooke's Cognitive Examination, Mattis Dementia Rating Scale, Frontal Assessment Battery and Mini Mental State Examination for diagnosing dementia in Parkinson's disease.
    Kaszás B; Kovács N; Balás I; Kállai J; Aschermann Z; Kerekes Z; Komoly S; Nagy F; Janszky J; Lucza T; Karádi K
    Parkinsonism Relat Disord; 2012 Jun; 18(5):553-6. PubMed ID: 22405839
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural changes in the retina and serum HMGB1 levels are associated with decreased cognitive function in patients with Parkinson's disease.
    Liang K; Li X; Guo Q; Ma J; Yang H; Fan Y; Yang D; Shi X; She Z; Qi X; Gu Q; Chen S; Zheng J; Li D
    Neurobiol Dis; 2024 Jan; 190():106379. PubMed ID: 38104911
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical validity of the Mattis Dementia Rating Scale-2 in Parkinson disease with MCI and dementia.
    Matteau E; Dupré N; Langlois M; Provencher P; Simard M
    J Geriatr Psychiatry Neurol; 2012 Jun; 25(2):100-6. PubMed ID: 22689702
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spectroscopic changes associated with mild cognitive impairment and dementia in Parkinson's disease.
    Pagonabarraga J; Gómez-Ansón B; Rotger R; Llebaria G; García-Sánchez C; Pascual-Sedano B; Gironell A; Delfino M; Ruscalleda J; Kulisevsky J
    Dement Geriatr Cogn Disord; 2012; 34(5-6):312-8. PubMed ID: 23208306
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Comparison of Serial Position Effects in Patients with Mild Cognitive Impairment due to Parkinson's Disease or to Alzheimer's Disease.
    Meyer A; Handabaka I; Ehrensperger MM; Gschwandtner U; Hatz F; Monsch AU; Stieglitz RD; Fuhr P
    Dement Geriatr Cogn Disord; 2020; 49(2):170-178. PubMed ID: 32634809
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.